WMA Declaration of Helsinki – Ethical Principles f... ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Ask the Heart Doctor | Heart Valve Disease and Sur...
Drug candidate slows motor neuron disease progress...
A Professional Overview of Hypertension ...
Long-term physical activity protects against metabolic syndr...
January 17,2026
Controlling hypertension can reduce dementia risk—even when ...
January 16,2026
Assessing methods for improving access to trauma care for ki...
January 15,2026
Portable device could help scientists track Alzheimer's dise...
January 14,2026
Neurons use physical signals, not electricity, to stabilize ...
January 13,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?

Red Cell Distribution Width (RDW) Blood Test Is High: What Does It Mean?Uses, Procedure, and ResultsByLynne Eldridge, MDUpdated on June 13, 2023Medically reviewed byDoru Paul,
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Dr. Fauci among hundreds who've contract...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
Announcement of the 2025 Nobel Prize in ...
More News
Findings suggest common salt activates anti-tumor cells

Findings suggest common salt activates anti-tumor cells

by Friederike Gawlik, Leibniz Institute for Natural Product Research and Infection BiologyImmune cells (purple and blue) attack tumor cells (red). Highly active CD8⁺ T cells treated with sodium chlori
Oncology September 10,2024
Findings suggest common salt activates anti-tumor cells

Findings suggest common salt activates anti-tumor cells

by Friederike Gawlik, Leibniz Institute for Natural Product Research and Infection BiologyImmune cells (purple and blue) attack tumor cells (red). Highly active CD8⁺ T cells treated with sodium chlori
Oncology September 10,2024
High-resolution brain tumor mapping reveals possible reason why some patients don't respond to new drug

High-resolution brain tumor mapping reveals possible reason why some patients don't respond to new drug

byWeizmann Institute of ScienceGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.029The cells that make up cancerous brain tumors are extremely varied and sometimes
Oncology September 10,2024
High-resolution brain tumor mapping reveals possible reason why some patients don't respond to new drug

High-resolution brain tumor mapping reveals possible reason why some patients don't respond to new drug

byWeizmann Institute of ScienceGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.029The cells that make up cancerous brain tumors are extremely varied and sometimes
Oncology September 10,2024
New anti-cancer 'degrader' targets protein essential to infant leukemia

New anti-cancer 'degrader' targets protein essential to infant leukemia

byVan Andel Research InstituteDiscovery of a first-in-class, highly potent VHL-recruiting ENL PROTAC degrader, MS41. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado1432Scienti
Oncology September 10,2024
New anti-cancer 'degrader' targets protein essential to infant leukemia

New anti-cancer 'degrader' targets protein essential to infant leukemia

byVan Andel Research InstituteDiscovery of a first-in-class, highly potent VHL-recruiting ENL PROTAC degrader, MS41. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado1432Scienti
Oncology September 10,2024
Potential new drug could target rare childhood brain tumor

Potential new drug could target rare childhood brain tumor

Potential new drug could target rare childhood brain tumorA type of glioma. Credit: David Ellison, St. Jude Children’s Research HospitalRibociclib—a drug already used to treat breast cancer—may help s
Oncology September 10,2024
Potential new drug could target rare childhood brain tumor

Potential new drug could target rare childhood brain tumor

Potential new drug could target rare childhood brain tumorA type of glioma. Credit: David Ellison, St. Jude Children’s Research HospitalRibociclib—a drug already used to treat breast cancer—may help s
Oncology September 10,2024
AI spots cancer and viral infections with nanoscale precision

AI spots cancer and viral infections with nanoscale precision

byCenter for Genomic RegulationThe image uses two colors to show specific nuclear components which allow researchers to see detailed structures within the cell nucleus at nanoscale resolution. C
Technology & AI September 10,2024
AI spots cancer and viral infections with nanoscale precision

AI spots cancer and viral infections with nanoscale precision

byCenter for Genomic RegulationThe image uses two colors to show specific nuclear components which allow researchers to see detailed structures within the cell nucleus at nanoscale resolution. C
Technology & AI September 10,2024
Innovations in cancer treatment through targeted bacterial vaccines

Innovations in cancer treatment through targeted bacterial vaccines

byScience China PressThe schematic illustrates how the nanovaccine induces robust anti-F. nucleatum immune responses that significantly improve the efficiency of chemotherapy and reduce cancer m
Oncology September 10,2024
Innovations in cancer treatment through targeted bacterial vaccines

Innovations in cancer treatment through targeted bacterial vaccines

byScience China PressThe schematic illustrates how the nanovaccine induces robust anti-F. nucleatum immune responses that significantly improve the efficiency of chemotherapy and reduce cancer m
Oncology September 10,2024
Exploring key regulators of programmed cell death in melanoma and the immune system's response

Exploring key regulators of programmed cell death in melanoma and the immune system's response

byBrigham and Women’s HospitalExpression of type I interferon receptors by melanoma cells. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-51496-2A new paperpublish
Dermatology September 10,2024
Exploring key regulators of programmed cell death in melanoma and the immune system's response

Exploring key regulators of programmed cell death in melanoma and the immune system's response

byBrigham and Women’s HospitalExpression of type I interferon receptors by melanoma cells. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-51496-2A new paperpublish
Dermatology September 10,2024
New prognostic biomarker identified in small cell lung cancer

New prognostic biomarker identified in small cell lung cancer

byChinese Academy of SciencesGraphical abstract. Credit:iScience(2024). DOI: 10.1016/j.isci.2024.110413Small cell lung cancer (SCLC) is a fast-growing and highly malignant subtype of
Oncology September 10,2024
New prognostic biomarker identified in small cell lung cancer

New prognostic biomarker identified in small cell lung cancer

byChinese Academy of SciencesGraphical abstract. Credit:iScience(2024). DOI: 10.1016/j.isci.2024.110413Small cell lung cancer (SCLC) is a fast-growing and highly malignant subtype of
Oncology September 10,2024
Identifying key markers in pancreatic cancer progression using a new analysis pipeline

Identifying key markers in pancreatic cancer progression using a new analysis pipeline

byJohns Hopkins UniversityNovel computational pipeline developed by Johns Hopkins Kimmel Cancer Researchers to identify early molecular and cellular progression to pancreatic ductal adenocarcino
Oncology September 10,2024
Identifying key markers in pancreatic cancer progression using a new analysis pipeline

Identifying key markers in pancreatic cancer progression using a new analysis pipeline

byJohns Hopkins UniversityNovel computational pipeline developed by Johns Hopkins Kimmel Cancer Researchers to identify early molecular and cellular progression to pancreatic ductal adenocarcino
Oncology September 10,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... Health spending has been rising across rich countries with different systems ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com